India’s Lorlatinib: Third-Gen ALK

So, Lorlatinib is this really cool third-generation med that works on these ALK and ROS1 inhibitors. It’s like a superhero drug for ALK-positive NSCLC, which is that type of lung cancer that has already gone through other treatments. And get this, it directly hits those ALK and ROS1 kinases to slow down tumor growth like it’s playing whack-a-mole with cancer.

You can get it in two different sizes – either 25 or 100 mg – all in those coated tablets. Now, they usually say to take 100 mg just once every day, food is optional, it doesn’t matter either way. These come in bottles with 30 pills each, it’s pretty straightforward stuff.